⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6685084 | 0.76 | — | — | |
| SCHEMBL3675360 | 0.63 | GSK3A (0.47) | — | |
| SCHEMBL3675358 | 0.63 | GSK3A (0.47) | — | |
| SCHEMBL7999251 | 0.59 | — | — | |
| SCHEMBL89327 | 0.59 | — | — | |
| SCHEMBL10915 | 0.59 | — | — | |
| Hydrochloric Acid SCHEMBL17363299 | 0.57 | — | — | |
| Methane SCHEMBL595114 | 0.57 | — | — | |
| SCHEMBL9525717 | 0.57 | — | — | |
| SCHEMBL5160944 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121428075-B | High-flux ubiquitin sample protein interaction screening method | 良渚实验室 | 2026-05-15 | — | — | CN | claimed |
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| US-12577558-B2 | Next generation sequencing | MORAVA INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20260071254-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | BECTON DICKINSON CO (US) | 2026-03-12 | — | — | US | claimed |
| EP-4189086-B1 | PURIFICATION OF SULFONATED DNA | EXACT SCIENCES CORP (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260022368-A1 | SYSTEMS AND METHODS FOR VARIANT DETECTION IN CELLS | UNIVERSITY OF WASHINGTON (US) | 2026-01-22 | — | — | US | claimed |
| US-20250376689-A1 | OLIGONUCLEOTIDES HAVING 6-THIO-2'-DEOXYGUANOSINE RESIDUES AND USES THEREOF | HOPE CITY (US) | 2025-12-11 | — | — | US | claimed |
| US-12421266-B2 | Diverse and flexible chemical modification of nucleic acids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-23 | — | — | US | claimed |
| EP-4612322-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | Becton, Dickinson and Company (US) | 2025-09-10 | — | — | EP | claimed |
| CN-120148625-A | Methods, apparatus, devices and program products for tumor detection | 上海小荷医学检验实验室有限公司 | 2025-06-13 | — | — | CN | claimed |
| EP-2231656-A1 | FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS | Amgen Inc. (US) | 2010-09-29 | — | — | EP | claimed |
| EP-2183228-A1 | CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 | Vitae Pharmaceuticals, Inc. (US) | 2010-05-12 | — | — | EP | claimed |
| WO-2009085185-A1 | FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS | AMGEN INC. (US) | 2009-07-09 | — | — | WO | claimed |
| WO-2009017664-A1 | CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | claimed |
| US-20040127440-A1 | Methods and compositions for control of bone formation via modulation of neuropeptide Y activity | BAYLOR COLLEGE OF MEDICINE | 2004-07-01 | — | — | US | claimed |
| US-20040053864-A1 | Methods and compositions for control of bone formation via modulation of neuropeptide y activity | BAYLOR COLLEGE OF MEDICINE | 2004-03-18 | — | — | US | claimed |
| WO-2001053477-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF BONE FORMATION VIA MODULATION OF NEUROPEPTIDE Y ACTIVITY | BAYLOR COLLEGE OF MEDICINE (US) | 2001-07-26 | — | — | WO | claimed |
| US-5710100-A | ANTIDOTES WITH HERBICIDES FOR CROPS SUCH AS CORN | MONSANTO COMPANY (US) | 1998-01-20 | — | — | US | claimed |
| WO-1990006118-A1 | THERAPEUTIC USE OF DIHYDROPYRIMIDONES AND BENZAZEPINE AND BENZOTHIAZEPINE DERIVATIVES IN RETINAL OR OPTIC NERVE DYSFUNCTION | HOUSTON BIOTECHNOLOGY INCORPORATED (US) | 1990-06-14 | — | — | WO | claimed |
| US-4695633-A | Chromogenic 4,4-diaryl-dihydroquinazolones, their preparation and their use | BAYER AKTIENGESELLSCHAFT (DE) | 1987-09-22 | — | — | US | claimed |